Seguir
Antonio Waldo Zuardi
Antonio Waldo Zuardi
Professor, School of Medicine of Ribeirão Preto, University of São Paulo
E-mail confirmado em fmrp.usp.br
Título
Citado por
Citado por
Ano
History of cannabis as a medicine: a review
AW Zuardi
Brazilian Journal of Psychiatry 28, 153-157, 2006
9552006
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients
MM Bergamaschi, RHC Queiroz, MHN Chagas, DCG De Oliveira, ...
Neuropsychopharmacology 36 (6), 1219-1226, 2011
9162011
Action of cannabidiol on the anxiety and other effects produced by δ9-THC in normal subjects
AW Zuardi, I Shirakawa, E Finkelfarb, IG Karniol
Psychopharmacology 76, 245-250, 1982
8431982
Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
S Bhattacharyya, PD Morrison, P Fusar-Poli, R Martin-Santos, ...
Neuropsychopharmacology 35 (3), 764-774, 2010
8242010
Safety and side effects of cannabidiol, a Cannabis sativa constituent
M Machado Bergamaschi, R Helena Costa Queiroz, A Waldo Zuardi, ...
Current drug safety 6 (4), 237-249, 2011
7102011
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
JAS Crippa, GN Derenusson, TB Ferrari, L Wichert-Ana, FLS Duran, ...
Journal of psychopharmacology 25 (1), 121-130, 2011
6382011
Cannabis and anxiety: a critical review of the evidence
JA Crippa, AW Zuardi, R Martín‐Santos, S Bhattacharyya, Z Atakan, ...
Human Psychopharmacology: Clinical and Experimental 24 (7), 515-523, 2009
6322009
Alcohol Use Disorders Identification Test (AUDIT): An updated systematic review of psychometric properties.
C de Meneses-Gaya, AW Zuardi, SR Loureiro, JAS Crippa
Psychology & Neuroscience 2 (1), 83, 2009
6322009
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi, JAS Crippa, JEC Hallak, FA Moreira, FS Guimarães
Brazilian journal of medical and biological research 39, 421-429, 2006
5882006
Distinct effects of Δ9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing
P Fusar-Poli, JA Crippa, S Bhattacharyya, SJ Borgwardt, P Allen, ...
Archives of general psychiatry 66 (1), 95-105, 2009
5802009
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
AW Zuardi
Brazilian Journal of Psychiatry 30, 271-280, 2008
5602008
Effects of ipsapirone and cannabidiol on human experimental anxiety
AW Zuardi, RA Cosme, FG Graeff, FS Guimarães
Journal of psychopharmacology 7 (1_suppl), 82-88, 1993
4421993
Cannabidiol for the treatment of psychosis in Parkinson’s disease
AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ...
Journal of Psychopharmacology 23 (8), 979-983, 2009
4382009
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial
MHN Chagas, AW Zuardi, V Tumas, MA Pena-Pereira, ET Sobreira, ...
Journal of Psychopharmacology 28 (11), 1088-1098, 2014
4062014
Antianxiety effect of cannabidiol in the elevated plus-maze
FS Guimarães, TM Chiaretti, FG Graeff, AW Zuardi
Psychopharmacology 100, 558-559, 1990
4051990
Effects of cannabidiol (CBD) on regional cerebral blood flow
JAS Crippa, AW Zuardi, GEJ Garrido, L Wichert-Ana, R Guarnieri, ...
Neuropsychopharmacology 29 (2), 417-426, 2004
3662004
Antipsychotic effect of cannabidiol.
AW Zuardi, SL Morais, FS Guimarães, R Mechoulam
The Journal of clinical psychiatry, 1995
3551995
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the …
RG Dos Santos, FL Osório, JAS Crippa, J Riba, AW Zuardi, JEC Hallak
Therapeutic advances in psychopharmacology 6 (3), 193-213, 2016
3372016
Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age
JA Crippa, FS Guimarães, AC Campos, AW Zuardi
Frontiers in immunology 9, 318736, 2018
3202018
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers
R Martin-Santos, J a Crippa, A Batalla, S Bhattacharyya, Z Atakan, ...
Current pharmaceutical design 18 (32), 4966-4979, 2012
2992012
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20